Table 2: Percentages of resistant isolates to listed antibiotics.
Antibiotic class |
antibiotic |
No. of G+ve bacteria |
No. of G-ve bacteria |
total |
Percentage of resistant isolates(out of 260) |
penicillin's |
AS |
88 |
100 |
188 |
72.3% |
|
TZP |
40 |
57 |
97 |
37.3% |
cephalosporin's |
CF |
71 |
88 |
179 |
68.8% |
quinolons |
CP |
44 |
29 |
73 |
28.1% |
|
LE |
15 |
7 |
22 |
8.5% |
|
OF |
26 |
21 |
47 |
18.1% |
aminoglycosides |
AK |
9 |
3 |
12 |
4.6% |
|
GM |
26 |
9 |
35 |
13.5% |
tetaracyclines |
TE |
76 |
98 |
174 |
66.9% |
chloramphenicol |
CH |
29 |
48 |
77 |
29.6% |
sulfonamides |
BA |
85 |
123 |
208 |
80% |
clindamycin |
CI |
53
|
82
|
135 |
51.9% |
Key: AS: Ampicillin sulbactam, TZP: Tazobactum piperacillin, CF: Cefotaxime, CP: Ciprofloxacin, LE: Levofloxacin, OF: Ofloxacin, AK: Amikacin, Gentamycin, TE: Tetracyclin, CH: Chloramphenicol, BA: Cotrimoxazole, CI: Clindamycin.
N= 260, this after subtracting Mycobacterium tuberculosis (95 isolates), Candida albicans (17 isolates) and Aspergillus (5 isolates) from the total (377).